Sec Form 4 Filing - Griffin William L. Jr @ WRIGHT MEDICAL GROUP INC - 2015-10-01

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Griffin William L. Jr 2. Issuer Name and Ticker or Trading Symbol WRIGHT MEDICAL GROUP INC [ WMGI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) SVP GM BioMimetic Therapeutics (Last) (First) (Middle) 1023 CHERRY ROAD 3. Date of Earliest Transaction (MM/DD/YY) 10/01/2015 (Street) MEMPHIS, TN38117 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10/01/2015 D 68,995 D 0 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (Right to Buy) $ 29.88 10/01/2015 D 100,000 ( 2 ) 07/22/2018 Common Stock 100,000 ( 3 ) 0 D Employee Stock Option (Right to Buy) $ 15.47 10/01/2015 D 11,811 ( 2 ) 05/13/2019 Common Stock 11,811 ( 4 ) 0 D Employee Stock Option (Right to Buy) $ 18.37 10/01/2015 D 9,886 ( 2 ) 05/13/2020 Common Stock 9,886 ( 5 ) 0 D Employee Stock Option (Right to Buy) $ 15.5 10/01/2015 D 12,855 ( 2 ) 05/11/2021 Common Stock 12,855 ( 6 ) 0 D Employee Stock Option (Right to Buy) $ 18.24 10/01/2015 D 1,975 ( 2 ) 04/16/2022 Common Stock 1,975 ( 7 ) 0 D Employee Stock Option (Right to Buy) $ 21.39 10/01/2015 D 20,067 ( 2 ) 05/09/2022 Common Stock 20,067 ( 8 ) 0 D Employee Stock Option (Right to Buy) $ 24.66 10/01/2015 D 19,948 ( 2 ) 05/14/2023 Common Stock 19,948 ( 9 ) 0 D Employee Stock Option (Right to Buy) $ 29.95 10/01/2015 D 17,594 ( 2 ) 05/13/2024 Common Stock 17,594 ( 10 ) 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Griffin William L. Jr 1023 CHERRY ROAD MEMPHIS, TN38117 SVP GM BioMimetic Therapeutics Signatures /s/ Marija S. Nelson, Attorney-in-fact 10/05/2015 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, Tornier N.V., Trooper Holdings Inc., and Trooper Merger Sub Inc., which became effective on October 1, 2015, in exchange for 71,126 Wright Medical Group N.V. ("Wright N.V.") ordinary shares having a market value of $20.39 per share at the effective time of the merger. ( 2 )The employee stock option vests in equal annual installments over a period of four years after the grant date. ( 3 )This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 103,090 Wright N.V. at a price of $28.99 per share. ( 4 )This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 12,175 Wright N.V. at a price of $15.01 per share. ( 5 )This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,191 Wright N.V. at a price of $17.82 per share. ( 6 )This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 13,252 Wright N.V. at a price of $15.04 per share. ( 7 )This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 2,036 Wright N.V. at a price of $17.70 per share. ( 8 )This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 20,687 Wright N.V. at a price of $20.75 per share. ( 9 )This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 20,564 Wright N.V. at a price of $23.93 per share. ( 10 )This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 18,137 Wright N.V. at a price of $29.06 per share.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.